Literature DB >> 1348146

Mediation of contraction and relaxation by alpha- and beta-adrenoceptors in the ureterovesical junction of the sheep.

L Rivera1, M Hernández, S Benedito, D Prieto, A García-Sacristán.   

Abstract

The effects of alpha- and beta-adrenoceptor agonists and antagonists were studied in the sheep ureterovesical junction. Non-specific adrenergic agonists such as adrenaline and noradrenaline induced contraction in the sheep ureterovesical junction, suggesting a predominance of alpha-over beta-adrenoceptors in this functional unity. An inhibition of the noradrenaline-induced contraction was observed after prior blocking with prazosin (10(-7) M) and yohimbine (10(-7) M), the effect of prazosin being more potent than that of yohimbine. The effect of phenylephrine on alpha 1-adrenoceptors was more potent than that of B-HT 920 on alpha 2-adrenoceptors. Isoproterenol caused a concentration-dependent relaxation that was inhibited by propranolol (10(-6) M), pafenolol (10(-5) M) and butoxamine (10(-5) M). These results suggest that ureterovesical junction contraction is mediated by both alpha 1 and alpha 2-adrenoceptors, alpha 1 predominating over alpha 2. Relaxation is mediated by beta-adrenoceptors of the beta 1 and beta 2 subtypes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348146     DOI: 10.1016/0034-5288(92)90058-a

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter.

Authors:  M Hernández; U Símonsen; D Prieto; L Rivera; P García; E Ordaz; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

2.  Noradrenaline modulates smooth muscle activity of the isolated intravesical ureter of the pig through different types of adrenoceptors.

Authors:  M Hernández; D Prieto; U Simonsen; L Rivera; M V Barahona; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.